Profit (Loss) (82.53) 90.67 (173.20) (191.02) Earnings per share (Baht per share) (0.02) 0.02 (0.04) (200.00) Net Profit The company and subsidiaries realized net loss as of the fiscal year 2015, ended as
) 90.67 (173.20) (191.02) Earnings per share (Baht per share) (0.02) 0.02 (0.04) (200.00) Net Profit The company and subsidiaries realized net loss as of the fiscal year 2015, ended as of December 31, 2015
200.83 (110.16) (54.85) Earnings per share (Baht per share) 0.08 0.25 (0.17) (68.00) Net Profit The company and subsidiaries realized net profit as of the fiscal year 2014, ended as of December 31, 2014 of
194.67 (104) (53.42) Earnings per share (Baht per share) 0.08 0.25 (0.17) (68.00) Net Profit The company and subsidiaries realized net profit as of the fiscal year 2014, ended as of December 31, 2014 of
Company's core businesses, especially the credit card income which having 18.2% growth y-y. Hence, the growth of revenue, especially credit cards, was mainly derived from marketing activities to stimulate
5,081 8% Income tax expenses 231 5% 967 1,000 3% 877 947 8% Net profit for the period 911 12% 3,690 3,553 -4% 3,811 4,133 8% Earnings Per Share (Baht per share) 3.64 12% 14.76 14.21 -4% 15.24 16.53 8% 3
Company and its subsidiary for the fiscal year ended on 31 December 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical
250.00% Net foreign exchange gain/(loss) 0.32 0.93 190.63% Other income 3.11 5.87 88.75% Earnings before interest and taxes 237.44 124.30 -47.65% Financial expense (2.31) (1.86) -19.48% Profit before
gain/(loss) 3.11 (0.35) -111.25% Other income 5.47 2.36 -56.86% Earnings before interest and taxes 86.99 64.97 -25.31% Financial expense (0.76) (2.30) 202.63% Profit before income tax expense 86.23 62.67